Healthcare Sector Review: Winning and Losing Stocks on Nov 30th

Wall St. Watchdog reveals information about today’s action in the Healthcare (NYSE:XLV) sector:

Gainers (% price change)

  • Progenics Pharmaceuticals (NASDAQ:PGNX): The shares closed at $6.72, up $1.16, or 20.86%, on the day. Its market capitalization is $226.89 million. About the company: Progenics Pharmaceuticals, Inc. is a biopharmaceutical company. The Company develops and distributes therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Progenics’ principal programs are directed toward supportive care, virology (human immunodeficiency virus and hepatitis C virus infections), and oncology. Get the most recent company news and stock data here >>
  • Metabolix, Inc. (NASDAQ:MBLX): The shares closed at $4.76, up $0.77, or 19.3%, on the day. Its market capitalization is $162.23 million. About the company: Metabolix, Inc. produces biobased, biodegradable, natural plastics and chemicals. Get the most recent company news and stock data here >>
  • Sangamo Biosciences, Inc. (NASDAQ:SGMO): The shares closed at $3.03, up $0.47, or 18.36%, on the day. Its market capitalization is $158.97 million. About the company: Sangamo BioSciences, Inc. researches and develops transcription factors in the regulation of genes. These transcription factors are the proteins that turn genes on and off and regulate gene expression by recognizing specific DNA sequences. Get the most recent company news and stock data here >>
  • Cornerstone Therapeutics (NASDAQ:CRTX): The shares closed at $5.84, up $0.85, or 17.03%, on the day. Its market capitalization is $151.98 million. About the company: Cornerstone Therapeutics, Inc. is a biopharmaceutical company that discovers, develops, and commercializes therapeutic products. The Company develops products that are designed to regulate the body’s inflammatory response associated with asthma and critical care diseases, and products for the respiratory market. Get the most recent company news and stock data here >>
  • Infinity Pharmaceuticals (NASDAQ:INFI): The shares closed at $9.13, up $1.23, or 15.57%, on the day. Its market capitalization is $243.58 million. About the company: Infinity Pharmaceuticals, Inc. researches and develops cancer drugs. The Company uses small molecule drug technologies in the development of its products. Get the most recent company news and stock data here >>

Losers (% price change)

  • China Medical Tech., Inc (NASDAQ:CMED): The shares closed at $3.32, down $0.2, or 5.68%, on the day. Its market capitalization is $107.59 million. About the company: China Medical Technologies, Inc. is a medical device company. The Company develops, manufactures, and markets products using high intensity focused ultrasound, or HIFU, for the treatment of diseases and disorders. China Medical Technologies, Inc. is based in Beijing. Get the most recent company news and stock data here >>
  • Watson Pharmaceuticals (NYSE:WPI): The shares closed at $64.62, down $2.67, or 3.97%, on the day. Its market capitalization is $8.22 billion. About the company: Watson Pharmaceuticals, Inc. develops, manufactures, and sells generic and brand name pharmaceutical products. The Company’s core focus is specialty products, nephrology, urology, and generic products. Get the most recent company news and stock data here >>
  • Affymetrix, Inc. (NASDAQ:AFFX): The shares closed at $4.52, down $0.11, or 2.38%, on the day. Its market capitalization is $318.54 million. About the company: Affymetrix, Inc. develops and manufactures DNA chip technology. The Company’s GeneChip system acquires, analyzes, and manages genetic information in order to improve the diagnosis, monitoring, and treatment of disease. Affymetrix’s product consists of DNA probe arrays containing gene sequences on a chip, a scanner to process the probe arrays, and software to analyze the information. Get the most recent company news and stock data here >>
  • Momenta Pharmaceuticals (NASDAQ:MNTA): The shares closed at $15.04, down $0.3, or 1.96%, on the day. Its market capitalization is $769.65 million. About the company: Momenta Pharmaceuticals, Inc. is a biotechnology company. The Company specializes in sequencing and engineering of complex sugars for the development of improved versions of existing drugs, the development of novel drugs, and the discovery of new biological processes. Momenta also develops technology-enabled generic products. Get the most recent company news and stock data here >>
  • RTI Biologics Inc. (NASDAQ:RTIX): The shares closed at $4.27, down $0.07, or 1.61%, on the day. Its market capitalization is $235.67 million. About the company: RTI Biologics, Inc. processes human and animal musculoskeletal tissues in producing allograft and xenograft implants. The Company’s products are used by surgeons to repair bone and other tissue defects, such as vertebrae repair, musculoskeletal reconstruction, fracture repair, joint repair and reconstruction for sports medicine injuries. Get the most recent company news and stock data here >>

(Note: Selected financial data are sourced from Google Finance. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More Articles About:   , , , , , ,  

More from The Cheat Sheet